These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 14272682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A DIPHTHERIA-TETANUS-POLIOMYELITIS VACCINE.
    DANE DS, DICK GW, HAIRE M, BRIGGS EM, CONNOR TJ.
    Lancet; 1965 Apr 24; 1(7391):877-9. PubMed ID: 14272681
    [No Abstract] [Full Text] [Related]

  • 4. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M, Lagercrantz R.
    J Pediatr; 1969 Jul 24; 75(1):30-8. PubMed ID: 4307138
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. SAFETY OF SABIN ORAL POLIOVACCINE STRAINS; MASS IMMUNIZATION PROGRAM IN LOS ANGELES COUNTY, 1962-1963.
    WEHRLE PF, LEEDOM JM, PORTNOY B, PIERCE NF, COWPER HH.
    JAMA; 1963 Nov 30; 186():821-6. PubMed ID: 14061062
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. THE PROTECTIVE EFFECT OF SALK VACCINE DURING AN EPIDEMIC OF POLIOMYELITIS, BRITISH COLUMBIA, 1959-1960.
    LARSEN AA.
    Can J Public Health; 1965 Feb 30; 56():47-50. PubMed ID: 14281078
    [No Abstract] [Full Text] [Related]

  • 9. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan 24; 46(RR-3):1-25. PubMed ID: 9026708
    [Abstract] [Full Text] [Related]

  • 10. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R, Li CG, Li Y, Liu Y, Zhao H, Chen X, Kuriyakose S, Van Der Meeren O, Hardt K, Hezareh M, Roy-Ghanta S.
    Vaccine; 2016 Mar 14; 34(12):1436-43. PubMed ID: 26873055
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR.
    Can Med Assoc J; 1964 Nov 21; 91(21):1118-22. PubMed ID: 14229761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. THE IMMUNIZING EFFECT OF A TWO-DOSE TRIVALENT ORAL POLIO VACCINE.
    CLAYTON LB, FLIPSE ME, HOFFERT WR, CROSSLEY MI.
    Curr Ther Res Clin Exp; 1965 Jan 21; 7():1-6. PubMed ID: 14246364
    [No Abstract] [Full Text] [Related]

  • 18. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH, Avila-Agüero ML, Brea del Castillo J, Mariño C.
    Rev Chilena Infectol; 2014 Oct 21; 31(5):590-603. PubMed ID: 25491459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Aug 07; 58(30):829-30. PubMed ID: 19661857
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.